Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment
NCT ID: NCT05583643
Last Updated: 2022-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
24 participants
INTERVENTIONAL
2021-12-07
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis
NCT02060032
Lepidium Sativum Extract Versus Simvastatin as an Adjunctive Local Delivery Agents to Non-Surgical Periodontal Therapy
NCT05657015
Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
NCT03009097
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
NCT02516111
Effect of Internal and External Micro-needling in Treatment of Stage III Periodontitis
NCT06578403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1 therapy
Scaling and debridement only
Scaling and debridement only
Phase 1 therapy with atorvastatin loaded into cubosomal in-situ gel
Atorvastatin Calcium
Atorvastatin loaded into nano particles in-situ gel adjunctive to scaling and debridement
Phase 1 therapy with atorvastatin loaded into in-situ gel
Atorvastatin Calcium
Atorvastatin loaded into in-situ gel adjunctive to scaling and debridement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atorvastatin Calcium
Atorvastatin loaded into nano particles in-situ gel adjunctive to scaling and debridement
Atorvastatin Calcium
Atorvastatin loaded into in-situ gel adjunctive to scaling and debridement
Scaling and debridement only
Scaling and debridement only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with moderate periodontitis
Exclusion Criteria
* Lactating women
* Patients with chronic diseases
25 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Misr University for Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heba Amin Elgendy
Teaching assistant - Pharmaceutics Department - Faculty of Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Misr University for Science and Technology (MUST)
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWA00025577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.